Ladenburg Thalmann Financial Services’s Ultragenyx Pharmaceutical RARE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$13K	Buy	279 +113	+68%	+$4.66K	﹤0.01%	4372
2019 Q3	$7K	Hold	166	–	–	﹤0.01%	4546
2019 Q2	$11K	Buy	166 +67	+68%	+$4.26K	﹤0.01%	4397
2019 Q1	$7K	Hold	99	–	–	﹤0.01%	4539
2018 Q4	$5K	Buy	+99	New	+$5.41K	﹤0.01%	4608
2018 Q3	–	Sell	-23	Closed	-$1K	–	5272
2018 Q2	$1K	Hold	23	–	–	﹤0.01%	5012
2018 Q1	$1K	Sell	23 -3,250	-99%	-$164K	﹤0.01%	5012
2017 Q4	$152K	Buy	3,273 +3,030	+1,247%	+$149K	﹤0.01%	2421
2017 Q3	$13K	Buy	243 +200	+465%	+$11.8K	﹤0.01%	3943
2017 Q2	$3K	Sell	43 -100	-70%	-$6.03K	﹤0.01%	4490
2017 Q1	$10K	Sell	143 -16	-10%	-$1.22K	﹤0.01%	3991
2016 Q4	$12K	Buy	159 +100	+169%	+$7.09K	﹤0.01%	3781
2016 Q3	$5K	Buy	59 +53	+883%	+$3.38K	﹤0.01%	4170
2016 Q2	$0	Hold	6	–	–	﹤0.01%	4818
2016 Q1	$0	Sell	6 -6	-50%	-$393	﹤0.01%	4777
2015 Q4	$1K	Hold	12	–	–	﹤0.01%	4533
2015 Q3	$1K	Buy	+12	New	+$1.37K	﹤0.01%	4441
2014 Q4	–	Sell	-8	Closed	–	–	4417
2014 Q3	$0	Buy	+8	New	+$403	﹤0.01%	4010

Other funds holding RARE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ladenburg Thalmann Financial Services's RARE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Ultragenyx Pharmaceutical (RARE) stake by 68% in Q4 2019, buying an estimated $4.66K and bringing the position to 279 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #4372.

Ladenburg Thalmann Financial Services first reported a position in RARE in Q3 2014 and has held it in 18 quarters since. The position peaked at $152K in Q4 2017. 173 funds tracked by Wall St. Rank hold RARE as of Q4 2019.

Ladenburg Thalmann Financial Services held 279 shares of Ultragenyx Pharmaceutical worth $13K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 113 Ultragenyx Pharmaceutical shares in Q4 2019, an estimated $4.66K.
Ultragenyx Pharmaceutical made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4372 holding.
Ladenburg Thalmann Financial Services first reported a position in Ultragenyx Pharmaceutical in Q3 2014 and has held it in 18 quarters since.
Ladenburg Thalmann Financial Services's Ultragenyx Pharmaceutical position peaked at $152K in Q4 2017.
173 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.